Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 07 - 27 tags : Treatment save search
Kronos Bio Announces FDA Clearance of Investigational New Drug Application for Lanraplenib (LANRA) for Treatment of Patients with Acute Myeloid Leukemia (AML)
Published: 2021-07-27 (Crawled : 22:00) - biospace.com/
KRON | $0.99 -3.88% -4.04% 120K
|
Health Technology
|
| O: 1.29%
H: 0.0%
C: -2.49%
new drug fda clearance treatment fda myeloid leukemia drug leukemia clearance acute myeloid leukemia aml
AliveCor and Acutus Medical Partner to Evaluate Management and Treatment of Cardiac Arrhythmias
Published: 2021-07-27 (Crawled : 21:00) - biospace.com/
AFIB | $0.167 -4.3% -4.49% 400K
|
Health Technology
|
| O: -1.04%
H: 3.74%
C: -2.43%
treatment
Zhongchao Inc. Builds A Platform for Breast Cancer Tiered Diagnosis and Treatment Improvement To Promote the Equalization of Breast Cancer Diagnosis and Treatment Level
Published: 2021-07-27 (Crawled : 13:00) - prnewswire.com
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
|
| O: -1.82%
H: 7.41%
C: 2.78%
treatment cancer breast cancer diagnostic
electroCore Announces Issuance of New Patent for Migraine Treatment using Smartphones
Published: 2021-07-27 (Crawled : 12:15) - globenewswire.com
ECOR | $6.0 6.38% 6.0% 7.4K
|
Health Technology
|
| O: 6.45%
H: 3.03%
C: -2.37%
treatment migraine patent
Day One Receives FDA Rare Pediatric Disease Designation for DAY101 for the Treatment of Pediatric Low-Grade Glioma
Published: 2021-07-27 (Crawled : 12:00) - biospace.com/
DAWN 4 | $14.98 -4.89% -5.14% 1.4M
|
Professional, Scientific, and T...
|
| O: 0.96%
H: 2.34%
C: -2.25%
disease treatment fda rare pediatric disease designation designation rare
Organon and ObsEva Enter Global License Agreement to Develop and Commercialize Ebopiprant (OBE022), an Investigational Agent Being Evaluated as a First-in-Class Treatment for Preterm Labor
Published: 2021-07-27 (Crawled : 05:00) - globenewswire.com
OBSV | $0.1018 -15.52% -18.95% 8.2M
|
Health Technology
|
| O: 19.84%
H: 18.54%
C: -4.97%
treatment license commercialization
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.